US Patent Issued to ANGIEX on Sept. 30 for "Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,477, issued on Sept. 30, was assigned to ANGIEX INC. (Cambridge, Mass.).

"Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same" was invented by Paul A. Jaminet (Sudbury, Mass.), Shou-Ching S. Jaminet (Sudbury, Mass.), Edward H. Ha (Cambridge, Mass.), Leonard G. Presta (San Francisco) and Manish S. Hudlikar (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody-drug conjugates (ADCs) are described, comprising anti-TM4SF1 antibodies, and antigen-binding fragments thereof. Methods of use of said ADCs are also described."

The patent was filed on Feb. 27, 2020, under Application No. 17/434,315.

*F...